Compositions and methods for the treatment of ocular disorders
AssigneesCase Western Reserve University, The Regents of the University of California, The United States Government as represented by the Department of Veterans Affairs
InventorsGregory Tochtrop, Philip Kiser, Jianye Zhang, Krzysztof Palczewski
Life of this patent
Estimating the term…
Abstract
A method of treating an ocular disorder in a subject in need thereof includes administering to the subject a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt, tautomer, or solvate thereof.
Claims26
A method of treating an ocular disorder in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically effective amount of a compound of formula (1):
- or a pharmaceutically acceptable salt, tautomer, or solvate thereof;
- wherein n is an integer from 0 to 6;
- R1 is a substituted or unsubstituted C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 aryl, heteroaryl, heterocyclyl, or C6-C12 alkaryl;
- R2, R4, and R5 are each independently H or F;
- R3 is H, F, or an alkyl or a fluoro alkyl group that includes at least three carbon atoms;
- R6 is H, CH3, or OH;
- R7 and R8 are H or D, wherein at least one of R7 or R8 is D if R2, R4, and R5 are H;
- and
- the dashed line is an optional bond.
10-22. (canceled)
A method of treating an ocular disorder in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically effective amount of a compound of formula (IV):
- or a pharmaceutically acceptable salt, tautomer, or solvate thereof;
- wherein R1 is a substituted or unsubstituted C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 aryl, heteroaryl, heterocyclyl, or C6-C12 alkaryl;
- R2 and R4 are each independently H or F;
- and
- R3 is H, F, or an alkyl or a fluoro alkyl group that includes at least three carbon atoms.
29-36. (canceled)
A method of treating an ocular disorder in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically effective amount of a compound selected from:
- or a pharmaceutically acceptable salt, tautomer, or solvate thereof.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.